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The current obesity epidemic is a major worldwide health and economic burden. In the modern 38 
environment, an increase in the intake of high-fat and high-sugar foods plays a crucial role in the 39 
development of obesity by disrupting the mechanisms governing food intake and energy balance. 40 
Food intake and whole-body energy balance are regulated by the central nervous system through a 41 
sophisticated neuronal network located mostly in the hypothalamus. In particular, the hypothalamic 42 
arcuate nucleus (ARC) is a fundamental center that senses hormonal and nutrient-related signals 43 
informing about the energy state of the organism. The ARC contains two small, defined populations 44 
of neurons with opposite functions: anorexigenic proopiomelanocortin (POMC)-expressing neurons 45 
and orexigenic Agouti-related protein (AgRP)-expressing neurons. AgRP neurons, which also co-46 
produce neuropeptide Y (NPY) and γ-Aminobutyric acid (GABA), are involved in an increase in 47 
hunger and a decrease in energy expenditure. In this review, we summarize the key findings from the 48 
most common animal models targeting AgRP neurons and the tools used to discern the role of this 49 
specific neuronal population in the control of peripheral metabolism, appetite, feeding-related 50 
behavior, and other complex behaviors. We also discuss how knowledge gained from these studies 51 
has revealed new pathways and key proteins that could be potential therapeutic targets to reduce 52 
appetite and food addictions in obesity and other diseases. 53 
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1. Introduction  70 
The hypothalamus is a region of the diencephalon located below the thalamus on each side of 71 
the third ventricle. It is composed of many small neuronal nuclei that integrate endocrine, nutritional 72 
and sensory signals, which culminate in the generation of precise neuroendocrine, behavioral, and 73 
autonomic responses aimed at controlling body homeostasis. Anatomically, the hypothalamus extends 74 
from the anterior commissure, lamina terminalis, and optic chiasm to the caudal limit of the 75 
mammillary bodies. Within these anatomical limits, hypothalamic nuclei are organized into the 76 
following zones and regions: preoptic area, composed of the medial and lateral preoptic nuclei; lateral 77 
zone, includes the lateral hypothalamic nucleus (LHA), and the tuberal nuclei; and the medial zone, 78 
subdivided into the anterior (or supraoptic) region, which contains supraoptic, paraventricular (PVH), 79 
suprachiasmatic, and anterior nuclei; the tuberal region, which contains ventromedial nuclei (VHM), 80 
the dorsomedial hypothalamic nucleus, and the arcuate nucleus (ARC); and finally the third region or 81 
mammillary part, which consists of the medial, intermediate, and lateral mammillary and posterior 82 
hypothalamic nuclei.  83 
 The first experiments connecting the hypothalamus with the regulation of energy balance 84 
and food intake were done by Hetherington and Ranson over 70 years ago. Their studies reported that 85 
lesions in the VHM nuclei of rats caused hyperphagia and obesity [1]. Later, Anand and Brobeck 86 
demonstrated in 1951 that bilateral destruction of the lateral portion of the LHA causes complete 87 
inhibition of food intake [2]. These results gave rise to the “dual-center hypothesis”, which suggests 88 
that VHM and LHA are the hypothalamic centers that regulate satiety and appetite respectively [3]. 89 
Nonetheless, following studies have further established that ARC nuclei play a more crucial role in 90 
the regulation of food intake and energy balance.  91 
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 The relevance of the ARC was identified with the discovery of the melanocortin system, 92 
which plays a key role in a number of homeostatic processes [4,5], and reviewed elsewhere [6,7] The 93 
melanocortin system consists of 1) melanocortin peptides (-, -, and -melanocyte-stimulating 94 
hormone (MSH) and adrenocorticotropic hormone) derived from the precursor proopiomelanocortin 95 
(POMC); 2) five melanocortin receptors (MCRs, MC1R-MC5R, MC3R and MC4R are particularly 96 
involved in food intake energy balance regulation), which are widely expressed in the hypothalamus; 97 
and 3) the endogenous melanocortin antagonist (AgRP). All these components are expressed mainly 98 
in two populations of hypothalamic neurons: neurons that co-produce AgRP, NPY, and GABA 99 
(AgRP/NPY neurons) [8,9] and neurons that co-produce POMC and cocaine and amphetamine-100 
stimulating hormone transcript (CART) (POMC/CART neurons) [10] Both are located at the base of 101 
the hypothalamus in close proximity to fenestrated capillaries. POMC/CART neurons and 102 
AgRP/NPY neurons exert opposite functions and are reciprocally regulated (Fig.1). While 103 
POMC/CART neurons express anorexigenic peptides and have appetite-suppressing functions, 104 
AgRP/NPY neurons express orexigenic peptides and have an appetite-stimulating role. NPY acts as 105 
a neurotransmitter in the brain and is thought to have several functions besides food intake, including 106 
regulation of fat storage [11]. The appetite-stimulating response to NPY is mediated by multiple NPY 107 
receptor subtypes, which are all Gi protein-coupled receptors. There are six identified NPY receptors, 108 
but the Y1 and Y5 isoforms are most strongly associated with the effect of NPY on feeding revised 109 
in [12]. Furthermore, AgRP/NPY neurons also release AgRP neuropeptide, a melanocortin antagonist 110 
that prevents the binding of α-MSH onto MC3R and MC4R, thus activating hunger [13]. AgRP/NPY 111 
neurons also release GABA. GABA is an inhibitory neurotransmitter, and may exert its orexigenic 112 
action through GABAergic-mediated inhibition of POMC/CART neurons [14].  113 
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 In recent decades, many animal models have been used to establish the relevance of this 114 
system in food intake and energy balance regulation. In this review, we analyze the techniques and 115 
approaches used to generate these animal models and their contribution to dissecting the molecular 116 
mechanisms and specific roles of AgRP/NPY neurons (thereafter AgRP neurons) on the modulation 117 
of peripheral glucose and lipid metabolism, thermogenesis, food intake, feeding behaviors, and other 118 
complex behaviors beyond feeding. We believe that this comprehensive review will help researchers 119 
in the field in search of specific pharmacological strategies to fight against excessive eating, obesity, 120 
and derived diseases.  121 
 122 
2. Animal models targeting the activity of AgRP neurons 123 
 One of the oldest genetic models that demonstrated the involvement of the agouti protein in 124 
energy balance regulation is the lethal yellow Ay mouse, which expresses the agouti protein in all 125 
tissues [15]. This mouse develops an obesogenic phenotype characterized by excessive food intake, 126 
hyperinsulinemia, and increased body weight. The study of Ay mice also showed that the agouti 127 
protein acts as an antagonist at MC1R and MC4R.. Subsequently, using knock-out techniques, the 128 
genetic deletion of MC4R (MC4R-KO) further contributed to the understanding of the melanocortin 129 
system and its role in energy homeostasis. MC4R-KO mice also display hyperphagia and obesity 130 
under free-feeding conditions [16,17]. Despite this, AgRP-deficient mice show normal food intake, 131 
body weight, and energy expenditure, and only a significant impairment in the regulation of body 132 
weight during aging [18]. Furthermore using the Cre-loxP system, a large number of genes have been 133 
deleted from AgRP neurons in an effort to dissect the molecular mechanisms involved in the main 134 
physiological roles of this set of neurons [14,19,20]. Taken together, these studies suggested that the 135 
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various components of the melanocortin system and specific AgRP genes might contribute differently 136 
to the regulation of food intake and energy balance, and thus motivated additional studies in the field.  137 
 In recent years, several biotechnological tools have been developed and applied to study the 138 
physiological role of AgRP neurons. The optogenetic approach combines genetic and optical methods 139 
to control and monitor the activity of single neurons in living tissues [21,22]. This groundbreaking 140 
technique is based on the expression of microbial opsins, such as channelrhodopsin (ChR) or 141 
halorhodopsin, which are light-gated proteins that directly regulate the flow of ions across the plasma 142 
membrane. Thus, in mice expressing opsins, light stimulation might inhibit or stimulate the activity 143 
of specific neuronal populations. The analogous pharmacosynthetic chemogenetic approach, known 144 
as the designer receptor exclusively activated by designer drugs (DREADDs), has also been used to 145 
control the activity of a single neuronal population in mice. The DREADDs system is based on the 146 
expression of a synthetic G-protein coupled receptor that responds to an exogenous inert ligand such 147 
as Clozapine-N-oxide (CNO, inert ligand). Indeed, DREADD technology has been widely used to 148 
control the activity of AgRP neurons by delivering CNO to the experimental animals [23,24].  149 
While these techniques have exposed the physiological functions of AgRP neurons, the 150 
undeniable demonstration of their critical role in the control of energy balance came from the study 151 
of AgRP neuron-ablated mice. This model was engineered to express the diphtheria toxin receptor 152 
(DTR) specifically in AgRP neurons (AgRPDTR), which caused the selective ablation of these neurons 153 
upon delivery of diphtheria toxin [25,26].  154 
Altogether, the results obtained using the above approaches have identified AgRP neurons as 155 
a key hypothalamic neuronal population that not only modulates food intake and feeding-related 156 
behaviors, but also whole-body energy homeostasis, through the control of peripheral glucose and 157 




3. AgRP neurons regulate peripheral metabolism 160 
3.1. AgRP neurons and glucose metabolism  161 
Every organism needs to match energy intake and expenditure to be able to subsist. Therefore, 162 
from a homeostatic perspective, hunger must be understood as a response emitted from the central 163 
nervous system in response to whole-body energy balance. For example, Horowitz M and colleagues 164 
showed in 1998 that physiological changes in blood glucose levels affect appetite [27]. Indeed, several 165 
decades ago, it had already been demonstrated that specific hypothalamic neurons can sense blood 166 
glucose concentrations. Yet, the precise molecular mechanisms underlying this observation are still 167 
incomplete.  168 
Activation of AgRP neurons promotes food seeking and intake. After a meal, blood glucose 169 
levels increase and, as a result, POMC neurons are activated. While the mechanisms underlying the 170 
excitatory actions of glucose on anorexigenic POMC neurons are clear, it is not completely 171 
understood yet if and how glucose could directly inhibit AgRP activity, as revised [28,29].  172 
Neurons could sense glucose levels through the ATP-dependent potassium (KATP) channels, 173 
which control potassium flow to depolarize or hyperpolarize the neuron membrane depending on the 174 
levels of ATP generated from glucose catabolism [28,30] (Fig. 2). The extracellular concentration of 175 
glucose in the brain is approximately 2.5 mM during the fed state and 0.5-0.2 mM during the fasted 176 
or hypoglycemic condition. POMC neurons increase spike firing when the concentration of brain 177 
glucose changes from 0.1 mM to 2 mM [31], and that is dependent on KATP channel subunits [32]. 178 
Conversely, the expression of a mutated KATP channel subunit that was insensitive to the ATP in 179 
POMC neurons impaired the whole-body response to a systemic glucose load [30].  180 
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It is unclear whether KATP channels are also involved in the glucose-dependent 181 
modulation of AgRP neurons. Even though KATP channels are expressed in AgRP neurons, 182 
probably because some of these neurons share a common progenitor with POMC neurons, only 183 
a minority of AgRP neurons are glucose responsive [29,31,33,34]. Yet, AgRP neurons respond to 184 
insulin levels. Insulin hyperpolarizes AgRP neurons in wild-type mice but not in those lacking the 185 
insulin receptor in AgRP neurons specifically (IRAgRP) [35]. Insulin inhibits AgRP neuronal activity 186 
by activating the phosphoinositide 3-kinase (PI3K) signaling pathway. The phosphatidylinositol-187 
3,4,5-triphosphate (PIP3) that is generated activates KATP channels, resulting in hyperpolarization and 188 
a decreased neuronal firing rate, with subsequent reduced release of AgRP [35]. PI3K activation 189 
ultimately leads to the exclusion of forkhead box O1 (FOXO1) transcription factor from the nucleus 190 
[36]. FOXO1 increases AgRP expression [37], thus insulin action in AgRP neurons ultimately 191 
decreases the expression of AgRP. This signaling pathway has also been described in POMC neurons, 192 
but in those neurons the exclusion of FOXO1 from the nucleus promotes POMC expression [38]. 193 
Taken together, these studies suggest that POMC neurons sense glucose levels, while AgRP neurons 194 
respond to changes in insulin concentration. 195 
In addition, AgRP neurons influence peripheral glucose metabolism. For instance, the ablation 196 
of these neurons in adult AgRPDTR mice caused a reduction in blood glucose levels 48 hours after the 197 
administration of diphtheria toxin [39]. One of the molecular explanations for this phenotype is the 198 
decreased hepatic gluconeogenesis observed in this model [35,40]. Accordingly, the acute activation 199 
of AgRP neurons using either a chemogenetic or optogenetic approach caused an increase in blood 200 
glucose levels due to systemic insulin resistance and decreased glucose uptake in brown adipose tissue 201 
(BAT) [24]. At molecular level, several genes in AgRP neurons have been associated with this 202 
regulation of whole-body glucose homeostasis. For instance, the deletion of purinergic receptor 6 203 
11 
 
(P2Y6) specifically in AgRP neurons, improved systemic insulin sensitivity in obese mice [41] and 204 
similar results have been observed when the transcription factor activating transcription factor 4 205 
(ATF4) was deleted specifically in AgRP neurons [42]. 206 
 207 
3.2. AgRP neurons and lipid metabolism 208 
 Fatty acids (FAs) are the primary fuel for most tissues under the fasting state. Therefore, FA 209 
levels are associated with the energy status of the organism. Importantly, FAs can cross the blood-210 
brain barrier and be oxidized in the brain. These observations raise the question of whether FAs could 211 
be a signal to AgRP neurons. It has been shown that intracerebroventricular (icv) administration of 212 
long-chain FAs inhibits the expression of NPY and AgRP in the hypothalamus, and therefore food 213 
intake [43]. Very recently, it has been reported that GPR120 and GPR40, also known as Free fatty 214 
acid receptor 1, are expressed in the hypothalamus of mice. The majority of cells that express POMC 215 
and AgRP also express GPR40 [44]. This receptor binds free FAs, acting as a nutrient sensor [44,45]. 216 
Of note, the icv administration of TUG905, which is an agonist of GPR40, reduces body weight [44]. 217 
The fact that GPR40 is expressed in AgRP and POMC neurons suggests that these cells could sense 218 
the content of FAs in the hypothalamus to regulate food intake and peripheral energy metabolism 219 
accordingly.  220 
Besides, most enzymes of the FA metabolic pathways are expressed in the hypothalamus, 221 
including AMP-activated protein kinase (AMPK) [46,47], acetyl-CoA carboxylase (ACC), carnitine 222 
palmitoyltransferase 1 (CPT1), fatty acid synthase (FAS), and malonyl-CoA decarboxylase (MCD) 223 
[48]. Of note, fasting stimulates hypothalamic AMPK and inhibits ACC and FAS activities, whereas 224 
re-feeding induces opposite changes [49,50]. Moreover, pharmacological and genetic manipulation 225 
of some of these genes/proteins has a profound impact on food intake and whole-body energy 226 
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homeostasis. For instance, icv administration of the FAS inhibitor cerulenin reduces feeding and 227 
causes weight loss due to the reduction of NPY and AgRP expression in the hypothalamus [51]. The 228 
anorectic effect of this drug requires the accumulation of malonyl-CoA in the hypothalamus, which 229 
in turn inhibits CPT1A, a key regulatory enzyme of the FA oxidation pathway. In agreement with 230 
these observations, the long-term increase of FA oxidation in the ventromedial hypothalamus, through 231 
the expression of a mutated and permanently active form of CPT1A, caused hyperphagia and 232 
increased body weight in rats [52]. Future studies are needed to elucidate whether enzymes from the 233 
FA metabolism pathway in specific ARC neuronal populations, i.e. AgRP or POMC neurons, play a 234 
role in the regulation of food intake and peripheral energy metabolism. 235 
Additionally, the hypothalamus regulates peripheral lipid metabolism and adiposity. For 236 
instance, disruption of melanocortin signaling in the brain promotes lipid uptake, triglyceride 237 
synthesis, and fat accumulation in white adipose tissue (WAT) [53]. Conversely, stimulation of MCRs 238 
reduces adiposity [54]. Within the hypothalamus, the activity of AgRP neurons impacts peripheral 239 
lipid metabolism. In fact, the activation of AgRP neurons promotes lipogenesis via the sympathetic 240 
nervous system (SNS) [55]. Additionally, the deletion of carnitine acyltransferase specifically in 241 
AgRP neurons increased FA utilization and attenuated the switch to glucose utilization after re-242 
feeding [56]. Moreover, the deletion of ATF4 specifically in AgRP neurons increases lipolysis in 243 
epididymal WAT, thus promoting fat loss [42]. Taken together, these results indicate that targeting 244 
the activity of AgRP neurons might be a good strategy to reduce adiposity in certain pathological 245 
conditions characterized by excessive fat accumulation, such as obesity. 246 
 247 
3.3. The role of AgRP neurons in thermogenesis 248 
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One of the first experiments that linked food intake with thermogenesis was completed by 249 
Rothwell A and Stock M in 1997. The study demonstrated that food consumption increases the 250 
activity of BAT through the SNS, which could be an important compensatory mechanism in case of 251 
energy surplus [57]. In addition, caloric restriction and feeding-fasting cycles also regulate body 252 
temperature and thermogenesis in BAT [58]. While it is known that sympathetic activity in BAT and 253 
WAT controls heat production and energy homeostasis [59], the same neurons that regulate energy 254 
intake may also control feeding-induced thermogenesis.  255 
Adipose tissue can be classified as WAT, which stores energy in the form of triglycerides, and 256 
BAT, which is highly oxidative and contains abundant mitochondria that oxidize FAs to generate heat 257 
via the BAT specific uncoupling protein 1 (UCP1). In response to specific stimuli, certain WAT 258 
depots can undergo a process known as browning where the tissue takes on characteristics of BAT, 259 
including the expression of UCP1. The icv infusion of AgRP gradually suppressed sympathetic tone 260 
in BAT thus decreasing thermogenesis [60]. Using the optogenetic approach, acute activation of 261 
AgRP neurons strongly inhibited the expression of thermogenic genes, including Ucp1, in 262 
retroperitoneal WAT, and to a lesser extent in inguinal WAT, which indicates that AgRP neurons 263 
suppress the browning of WAT [61]. While the inhibition of AgRP neuronal activity by selectively 264 
deleting the O-GlcNAc transferase caused WAT browning in those mutant mice [61] 265 
The hormone ghrelin, which is released from the empty stomach, acts on AgRP neurons 266 
through its receptor (GHS-R) to activate food consumption. Deletion of GHS-R specifically in AgRP 267 
neurons (AgRP-Cre;Ghsrf/f mice) caused increased energy expenditure in mice fed a HFD, and 268 
enhanced thermogenic activation in both BAT and subcutaneous WAT [62].  Overall, the role of 269 
AgRP neurons in thermogenesis could be an important target to increase energy expenditure and thus 270 




4. The role of AgRP neurons in food intake 273 
There are numerous neurons distributed in the brain that influence appetite [63], yet AgRP 274 
neurons within the hypothalamus are probably the neuronal population that has the strongest and most 275 
closely documented association with feeding behavior [64,65]. The first evidence supporting the role 276 
of AgRP neurons in food intake control came from experiments showing that AgRP and NPY 277 
injection in the brain increase food intake. It was also drawn from the observation the AgRP and NPY 278 
release is higher in brain sections of food-deprived mice [66,67].  279 
These early results have been confirmed recently by using the innovative cell type-specific 280 
approaches mentioned in Section 2 of this review. For example, optogenetic and pharmacogenetic 281 
activation of AgRP neurons result in a robust increase in food intake, even in fed mice [68,69]. 282 
Moreover, ablation of AgRP neurons in adult, but not neonatal, mice results in an acute reduction of 283 
feeding and starvation [25,26,70]. The differences observed between neonatal and adult mice suggest 284 
that network-based compensatory mechanisms can occur in neonates but not in the adult stage [71]. 285 
Surprisingly, deletion of the entire Agrp coding sequence using BAC-based targeting vectors did not 286 
generate differences in food intake or body weight in adult mice before 6 months of age [38]. 287 
Likewise, deletion of Npy had little effect on body weight control [72,73]. These observations suggest 288 
that GABA, also produced by AgRP neurons, might be a critical neurotransmitter regulating food 289 
intake and energy balance. Actually, disruption of GABA signaling by selective inactivation of the 290 
vesicular GABA transporter gene (Vgat) in AgRP neurons caused a lean phenotype and protected 291 
mice from diet-induced obesity [14]. Accordingly, chronic and subcutaneous delivery of bretazenil (a 292 
GABAA receptor partial agonist) prevented starvation in AgRP neuron-ablated mice [74]. 293 
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GABA is an inhibitory neurotransmitter and thus GABAergic input from AgRP neurons 294 
inhibits the activity of several neuronal populations within the brain, including POMC neurons from 295 
the ARC. This crosstalk between orexigenic and anorexigenic neurons in the ARC is essential for the 296 
precise regulation of food intake [65]. In addition, GABAergic projections from AgRP neurons also 297 
suppress the activity of neurons in the PVH [75]. Because activation of PVH neurons decreases 298 
feeding [76], it has been suggested that AgRP neurons increase food intake in part through the 299 
GABAergic inhibition of PVH neurons. Another important GABAergic target of AgRP neurons is 300 
the parabrachial nuclei (PBN). However, in this nucleus the effect of GABA promotes feeding, 301 
since administration of bretazenil (a GABA(A) receptor partial agonist) into the PBN prevents 302 
starvation in AgRP neuron-ablated mice [74]. 303 
Independently of the neurotransmitter released, there are many areas in the brain under the 304 
control of AgRP neurons that regulate feeding behavior. Elegant optogenetic experiments by Brüning 305 
and colleagues confirmed previous studies showing that AgRP neurons control neurons in the PVH 306 
to influence feeding. Likewise, they showed that LHA and the anterior bed nucleus of the stria 307 
terminalis (aBNST) dorsomedial nucleus were activated by AgRP projections to promote feeding, 308 
while the dorsal vagal complex, dorsal raphe nucleus  and aBNST ventral lateral nucleus were not 309 
[24]. Overall, this study suggested that AgRP neurons orchestrate the activation and inactivation of 310 
various brain areas to promote food seeking and intake. 311 
Now the question is: what is the mechanism by which AgRP neurons are activated upon 312 
starvation? A large amount of evidence indicates that ghrelin action on these neurons leads to their 313 
activation. Ghrelin is a 28-amino acid peptide produced in the stomach. Ghrelin blood levels increase 314 
preprandially and decrease postprandially. Ghrelin increases food intake by activating its receptor 315 
GHS-R in AgRP neurons [77,78] (Fig .3). Of note, ghrelin administration increases AgRP firing in 316 
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brain slices from control mice but not from mice lacking Ghsr specifically in AgRP neurons 317 
(GhsrAgRP-/-) [79]. Ghrelin increases the mRNA levels of NPY and AgRP in AgRP neurons, yet the 318 
molecular mechanism remains partially unclear [80]. It has been suggested that the AMPK-CPT1A-319 
UCP2 axis is a relevant pathway in the ARC, which is involved in ghrelin’s control of food intake 320 
[81]. AMPK is a downstream target of GHS-R, and upon its activation it inhibits ACC, thus 321 
decreasing the intracellular levels of malonyl-CoA. Malonyl-CoA is the physiological inhibitor of 322 
CPT1A, which is the rate-limiting step in the mitochondrial FA oxidation pathway. Increased FA 323 
oxidation generates reactive oxygen species (ROS) and subsequent uncoupling protein-2 (UCP2) 324 
activity. Using a mouse model lacking Ucp2 in all cells, it had been suggested that UCP2 mediates 325 
ghrelin’s actions on AgRP neurons by lowering free radicals [82]. However, cell-type specific studies 326 
are needed to clarify the role of UCP2 in AgRP neurons in regulating food intake. 327 
Another proposed candidate to mediate ghrelin’s orexigenic action in the ARC is the NAD+-328 
dependent class III deacetylases SIRT1. Sirt1 is expressed in the hypothalamus, its function is redox 329 
dependent, and it is induced by negative energy balance. In fact, central administration of ghrelin 330 
increases SIRT1 activity in the hypothalamus and blockade of SIRT1 abolished the orexigenic effect 331 
of this hormone [83]. Another study showed that the Sirtuin 1/p53 pathway is essential for the 332 
orexigenic action of ghrelin [84]. Of note, cell-type specific ablation of Sirt1 (Sirt1AgRP-/- mice) in 333 
AgRP neurons determined that this neuronal population mediates the action of SIRT1 on energy 334 
balance: Sirt1AgRP-/- mice show decreased electric responses of AgRP neurons to ghrelin, decreased 335 
food intake, decreased lean mass, fat mass, and body weight [83].  336 
Finally, ghrelin stimulates AgRP and NPY neuropeptide expression through the activation of 337 
transcriptional factors, such as Brain specific homeobox (BSX) protein. BSX needs to interact with 338 
another two transcription factors to activate Agrp and Npy mRNA expression: FOXO1 for the Agrp 339 
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gene and the phosphorylated cAMP response-element-binding protein (pCREB) for the Npy gene 340 
[85]. Yet, the activation of BSX downstream of the AMPK-ACC-CPT1A-UCP2 axis remains unclear. 341 
Nonetheless, it has been demonstrated that FOXO formed a complex with SIRT1 in response to 342 
oxidative stress [86] and enhances FOXO transcriptional activity [87], but so far there is no evidence 343 
that all these events occur specifically in neuronal cells.  344 
 345 
5. AgRP neurons regulate complex behaviors beyond feeding  346 
As reviewed in the previous sections, hypothalamic neurons that co-produce NPY, AgRP, and 347 
GABA are fundamental in the regulation of food intake and peripheral metabolism. In addition, the 348 
study of animal models targeting the activity of AgRP neurons has revealed that these cell populations 349 
also coordinate other complex behaviors beyond feeding. Mice with compromised AgRP neuronal 350 
excitability (Sirt1AgRP-/- mice) exhibit greater locomotor activity and exploratory behavior than 351 
control littermates during an open field test (OFT) [88]. The same is true in AgRP-neuron-ablated 352 
mice. Conversely, brain infusion of AgRP in rats reduces locomotor activity [89]. The OFT is an 353 
approach/avoidance assay based on the fact that a novel environment (an open field box) evokes both 354 
anxiety and exploration in the experimental animal [90]. Therefore, the increased exploratory 355 
behavior observed in Sirt1AgRP-/- and AgRP-neuron-ablated mice suggests that activity of AgRP 356 
neurons regulates anxiety-like behaviors in rodents. In addition, Sirt1AgRP-/- mice and AgRP-neuron-357 
ablated mice show an increased response and preference for cocaine, suggesting that AgRP neurons 358 
also affect reward circuits [88]. Exploring this possibility revealed that AgRP fibers innervate the 359 
ventral tegmental area (VTA) in the midbrain, where dopaminergic neurons responsible for reward 360 
seeking are located [88]. Intriguingly, the activation of AgRP neurons also decreases anxiety during 361 
an OFT and an elevated plus-maze (EPM) test [91]. During an EPM test, anxiety-like behaviors 362 
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inversely correlate with the time that animals spend in the open arms of an EPM apparatus comprised 363 
of two open and two enclosed arms elevated from the floor [92]. The fact that the activation and 364 
ablation of AgRP neurons causes an apparently similar decrease in anxiety-like behaviors requires 365 
further investigation. However, it also highlights the role of hypothalamic AgRP neurons in regulating 366 
complex behavior. Additionally, activation of hypothalamic AgRP neurons in the absence of food 367 
stimuli triggers foraging and other stereotypic behaviors [91]. Of note, some aspects of these 368 
stereotypic behaviors are not seen in food-deprived animals, which suggests that subpopulations of 369 
AgRP neurons have different functions. Altogether, these observations revealed a previously 370 
unsuspected role for hypothalamic AgRP neurons in controlling complex behaviors beyond feeding 371 
in mice. 372 
 373 
6. Pharmacological modulation of AgRP neurons 374 
New insights into the neuronal circuit to control feeding behaviors and energy homeostasis are 375 
essential to devise specific pharmacological strategies that could be useful to treat obesity and its 376 
complications.  377 
Many receptors expressed in AgRP neurons have been identified to understand which 378 
molecule could be useful for pharmacological manipulation (Table 1). A recent finding revealed that 379 
norepinephrine (NE) activates AgRP neurons due to α1A-Ars, which suggests an orexigenic influence 380 
of NE in ARC nuclei [93]. Furthermore, Uridine-diphosphate (UD) and its receptor P2Y6 have 381 
recently been identified as regulators of AgRP neurons that promote feeding through the activation 382 
of these neurons [41]. Interestingly, AgRP neurons express angiotensin AT1A receptor and the lack of 383 
this receptor exhibits attenuated BAT sympathetic nerve activity in response to leptin, which suggests 384 
that some AT1A agonists and antagonists could be useful to modulate energy expenditure [94]. Many 385 
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of these receptors belong to the GPCR family receptors with distinct coupling G protein associated. 386 
It seems that Gs protein has a strong association with food intake because the activation of Gs-coupled 387 
receptor expressed by AgRP neurons leads to a robust increase in food intake [95]. Alternatively, key 388 
regulatory factors of AgRP activation such as Sirt1 could be interesting targets to control food intake. 389 
It has been demonstrated that the Sirt1 inhibitor (EX-527) injected peripherally or icv decreased food 390 
intake during the dark cycle and ghrelin-induced food intake [83]. Altogether, this indicates that there 391 
is a need for further studies to discover new therapeutic targets and their efficient drugs.  392 
However, the aforementioned receptors and ligands belong to a ubiquitous system and 393 
therefore new approaches are necessary to target exclusively specific neuronal populations, 394 
such as AgRP. One possibility is the use of chemogenetic tools. Usually, these technologies 395 
involve genetically targeting the sensitivity to an otherwise inert small ligand. For example, the 396 
group of Sternson has developed chemogenetic technologies (such as the pharmacologically 397 
selective actuator modules/pharmacologically selective effector molecule - PSAM/PSEM) that 398 
could be applied in conjunction with gene therapies in humans to target specific cell populations. 399 
Noteworthy, PSAM/PSEM has been already used in mice to silence specifically AgRP neurons, 400 
which resulted in a suppression of food intake and learning enhancement [96]. In addition, 401 
chemogenetic approaches have been used in mice to induce dimerization of proteins, 402 
destabilization of domains or inhibition of engineered kinases in a cell-specific manner [97].  403 
Alternatively, enormous research efforts have been focused on brain drug delivery to 404 
develop new therapies for brain disease. Recent studies have analysed new tools to enhance the 405 
delivery of drugs across the blood brain barrier and drug uptake by neurons. Some of these 406 
tools include nanocarriers that transport bioactive substances to a target site [98]. 407 
Unfortunately, currently none of these strategies has accomplished a cell-specific drug 408 
20 
 
delivery. Nonetheless, these technologies provide an exciting prospect for the future 409 
development of human therapies. 410 
 411 
7. Conclusions and future directions 412 
The mouse genetic revolution has shown repeatedly that hypothalamic neurons are crucial in the 413 
regulation of appetite and whole-body energy balance. In particular, data from all these animal studies 414 
have highlighted AgRP and POMC neurons as key components of the neuronal circuits that control 415 
food intake and peripheral energy metabolism. In this review, we have focused deliberately on AgRP 416 
neurons because of the vast number of animal models targeting this specific neuronal population. In 417 
summary, all these in vivo studies have established that AgRP neurons integrate interoceptive, 418 
nutritional, endocrine, and sensory information to coordinate goal-directed behavior, such as food 419 
seeking and intake. Thus, activation of AgRP neurons stimulates feeding as well as a rapid decrease 420 
in energy expenditure. At the molecular level, several genes and proteins have been identified as 421 
potential players controlling AgRP neuronal function. These include receptors for hormones, such as 422 
insulin and ghrelin, enzymes of the FA metabolism pathway, SIRT1, and transcription factors such 423 
as ATF4. Of note, many of these molecules might be potential targets in the treatment of eating 424 
disorders, i.e. anorexia nervosa or compulsive eating, and metabolic diseases such as obesity.  425 
Moving forward, it remains crucial to question whether differences in AgRP neuronal function exist 426 
between individuals vulnerable or invulnerable to developing disorders characterized by dysregulated 427 
energy balance. Moreover, future studies are needed to determine whether specific subpopulations of 428 
AgRP neurons are responsible for the regulation of food intake and other aspects of energy 429 
homeostasis. Lastly, considering the heterogeneity of the hypothalamus and the opposite functions of 430 
different hypothalamic neuronal populations, we believe that future efforts must be focused on 431 
21 
 
developing cell-type specific drug delivery methods, in order to design efficient and safe treatments 432 
for eating disorders, obesity, and related pathologies. 433 
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Figure legends 810 
 811 
Figure 1: Melanocortin system. AgRP/NPY and POMC/CART neurons are located at the base of 812 
the hypothalamus in close proximity to fenestrated capillaries. POMC neurons exert an anorexigenic 813 
function and increase energy expenditure through the expression of the post-transcriptional product 814 
of the POMC gene, including α-melanocyte-stimulating hormone (α-MSH), β-MSH, Ɣ-MSH that 815 
binds to the melanocortin receptor (MCR), an anorexigenic target. NPY/AgRP neurons increase food 816 
intake and decrease energy expenditure through the release of neuropeptide Y (NPY), γ- amino-817 
butyric acid (GABA), and agouti-related protein (AgRP). NPY act through NPY1R and NPY5R, 818 
while AgRP antagonize α-MSH action and GABA is an inhibitory neurotransmitter that exerts 819 
orexigenic action through GABAergic-mediated inhibition of POMC neurons. 820 
 821 
Figure 2: Glucose and insulin pathways´connection between the CNS and peripheral system..1) 822 
Meal consumption increases glucose levels, which depolarize POMC neurons due to the increase in 823 
the ATP/ADP ratio that closes the KATP channel. 2) In AgRP neurons, the increase in glucose level 824 
causes AKT phosphorylation that activates neuronal nitric oxide synthase (nNOS) and produces nitric 825 
oxide (NO). NO binds to soluble guanylyl cyclase (sGC) increasing cyclic guanosine monophosphate 826 
(cGMP) levels. cGMP activates protein kinase GII (PKGII) that phosphorylates the cystic fibrosis 827 
transmembrane conductance regulator (CFTR), increasing conductance to the chloride channel and 828 
hyperpolarizing the neuron. 3) The insulin produced as a result of an increase in glucose level 829 
inactivates AgRP neurons as a feedback mechanism. Insulin acts on AgRP neurons through insulin 830 
receptor (IR). Insulin receptor substrate (IRS) proteins bind to phosphorylated residues on the IR to 831 
activate phosphoinositide 3 kinase (PI3K) that produces phosphatidylinositol 3 phosphate (PIP3) from 832 
39 
 
phosphatidylinositol 2 phosphate (PIP2). PIP3 activates KATP, resulting in hyperpolarization and 833 
decreasing the firing rate. Phosphoinositide-dependent kinase 1 (PDK1) binds to PIP3 and activates 834 
AKT, which enters the nucleus and leads to the exclusion of the forkhead box O (FOXO) 1, which 835 
decreases AgRP transcription. 4) The inhibition of AgRP neurons increases the expression of hepatic 836 
IL-6 through liver innervation. IL-6 activates Janus kinase/signal transducers and activators of the 837 
transcription (Jack-STAT) pathway that inhibits the expression of glucose-6-phosphatase (G6Pase), 838 
thereby suppressing hepatic gluconeogenesis. The insulin signaling pathway has also been described 839 
in POMC neurons, but the exclusion of FOXO1 from the nucleus promotes POMC transcriptional 840 
activation. 841 
 842 
Figure 3: Ghrelin signaling pathway in AgRP neurons. Ghrelin activates the growth hormone 843 
secretagogue receptor 1a (GHSR1a), a G couple receptor that interacts with Gq protein. The G alpha 844 
subunit recruits phospholipase C (PLCß) that produces inosito-1,4,5-triphosphate (IP3), which 845 
increases the Ca++ level and interacts with calmodulin (CaM) to activate CaM-dependent protein 846 
kinase kinases (CaMKK). This enzyme phosphorylates AMPK, which phosphorylates acetyl-CoA 847 
carboxylase (ACC). ACC activation causes a reduction in malonyl-CoA and disinhibition of carnitine 848 
palmitoyl transferase 1 (CPT1). The CPT1A enzyme increases long chain fatty acid (LCFA) transport 849 
into mitochondria for oxidation. Increased fatty-acid oxidation results in an increase of reactive 850 
oxygen species (ROS) and subsequent uncoupling protein-2 (UCP2) activity, which helps to buffer 851 
intracellular ROS. UCP2 acts as a critical mitochondrial biogenic signal that further enhances the 852 
bioenergetic capacity of AgRP neurons and ensures efficient transcription of AgRP and NPY genes 853 
through the transcriptional factors BSX with FoxO1 and pCREB. The Sirtuin 1/p53 pathway is 854 






Table 1. Receptors expressed in AgRP neurons  857 
 858 
Receptor Type Ligand Function Reference 




Adenosine Astrocytes inhibit AgRP 






Angiotensin Contribute to the control of 






Glutamate Control of body weight, body 
fat, food intake, glucose 
homeostasis. 
[20,100] 
Glucocorticoid receptors Nuclear receptor Glucocorticoids Control of body weight and 
energy expenditure  
[101] 
Insulin receptor  Tyrosine kinase receptors Insulin Control of body weight and 
food intake  
[35,102] 
Leptin receptor LepR  Type I cytokine receptor Leptin  Control of food intake [103] 
α2A – adrenergic receptors G protein-coupled 
receptors 
Noradrenalin Feeding and food intake [93] 
Corticotropin-releasing 





hormone (CRH)  















Food intake and systemic 
insulin sensitivity in obesity 
[41,105] 




N-oleoylglycine (OLGly) Food intake [106] 










Unknown endogenous ligand 
Energy balance and glucose 
homeostasis 
[108] 
Polyunsaturated fatty acid 
(PUFA) receptors GPR40 
G protein-coupled 
receptors 
Polyunsaturated fatty acid 
 
Body weight mass regulation [44] 
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